Correlation Between HELIX BIOPHARMA and Brockhaus Capital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HELIX BIOPHARMA and Brockhaus Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HELIX BIOPHARMA and Brockhaus Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HELIX BIOPHARMA and Brockhaus Capital Management, you can compare the effects of market volatilities on HELIX BIOPHARMA and Brockhaus Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HELIX BIOPHARMA with a short position of Brockhaus Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of HELIX BIOPHARMA and Brockhaus Capital.

Diversification Opportunities for HELIX BIOPHARMA and Brockhaus Capital

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between HELIX and Brockhaus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding HELIX BIOPHARMA and Brockhaus Capital Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brockhaus Capital and HELIX BIOPHARMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HELIX BIOPHARMA are associated (or correlated) with Brockhaus Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brockhaus Capital has no effect on the direction of HELIX BIOPHARMA i.e., HELIX BIOPHARMA and Brockhaus Capital go up and down completely randomly.

Pair Corralation between HELIX BIOPHARMA and Brockhaus Capital

If you would invest  115.00  in HELIX BIOPHARMA on September 4, 2024 and sell it today you would earn a total of  0.00  from holding HELIX BIOPHARMA or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

HELIX BIOPHARMA  vs.  Brockhaus Capital Management

 Performance 
       Timeline  
HELIX BIOPHARMA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HELIX BIOPHARMA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, HELIX BIOPHARMA is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Brockhaus Capital 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brockhaus Capital Management has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

HELIX BIOPHARMA and Brockhaus Capital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HELIX BIOPHARMA and Brockhaus Capital

The main advantage of trading using opposite HELIX BIOPHARMA and Brockhaus Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HELIX BIOPHARMA position performs unexpectedly, Brockhaus Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brockhaus Capital will offset losses from the drop in Brockhaus Capital's long position.
The idea behind HELIX BIOPHARMA and Brockhaus Capital Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Directory
Find actively traded commodities issued by global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios